Stay updated on Safety of COVID-19 RNA Vaccine in Healthy Individuals Clinical Trial
Sign up to get notified when there's something new on the Safety of COVID-19 RNA Vaccine in Healthy Individuals Clinical Trial page.

Latest updates to the Safety of COVID-19 RNA Vaccine in Healthy Individuals Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe webpage has undergone significant updates, including the removal of detailed descriptions of a Phase 1/2/3 study for a SARS-CoV-2 vaccine and the addition of new collaborators and links for obtaining contact information for study centers.SummaryDifference15%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check73 days agoChange DetectedThe webpage has removed information regarding heavy traffic affecting NLM-NCBI services and products, as well as helpful links provided by BioNTech SE for obtaining contact information for study centers.SummaryDifference0.7%
- Check88 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.4%
Stay in the know with updates to Safety of COVID-19 RNA Vaccine in Healthy Individuals Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of COVID-19 RNA Vaccine in Healthy Individuals Clinical Trial page.